Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade-Reference-Cited by-同舟云学术

Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade

Published:2018-12-18 Issue:1 Volume:141 Page:205-211
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Iwadate Yasuo^ORCID,Matsutani Tomoo,Hara Ayaka,Hirono Seiichiro,Ikegami Shiro,Kobayashi Masayoshi,Ito Daisuke,Kawauchi Daisuke,Horiguchi Kentaro,Tamiya Ado,Higuchi Yoshinori

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/article/10.1007/s11060-018-03027-5/fulltext.html

Reference38 articles.

1. Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M (2017) Advances in the molecular genetics of gliomas—implications for classification and therapy. Nat Rev Clin Oncol 14:434–452

2. Mason WP, Krol GS, DeAngelis LM (1996) Low-grade oligodendrogliomas respond to chemotherapy. Neurology 46:203–207

3. Celli P, Nofrone I, Palma L, Cantore G, Fortuna A (1994) Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery 35:1018–1034

4. Leonardi MA, Lumenta CB (2001) Oligodendrogliomas in CT/MR-era. Acta Neurochir 143:1195–1203

5. Lebrun C, Fontaine D, Ramaioli A et al (2004) Long-term outcome of oligodendrogliomas. Neurology 62:1783–1787

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy;Brain Tumor Pathology;2024-04

2. A 10-Year Survival-Trend Analysis of Low-Grade Glioma and Treatment Patterns from an LMIC;Asian Journal of Neurosurgery;2023-09

3. T2‐Fluid‐attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone;European Journal of Neurology;2023-05-31

4. Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution;Brain Tumor Pathology;2023-04

5. Evolved WHO Classification and Therapeutics Strategy for Low-grade Gliomas;Japanese Journal of Neurosurgery;2023